199 related articles for article (PubMed ID: 35045343)
21. Prospective phenotyping of NGLY1-CDDG, the first congenital disorder of deglycosylation.
Lam C; Ferreira C; Krasnewich D; Toro C; Latham L; Zein WM; Lehky T; Brewer C; Baker EH; Thurm A; Farmer CA; Rosenzweig SD; Lyons JJ; Schreiber JM; Gropman A; Lingala S; Ghany MG; Solomon B; Macnamara E; Davids M; Stratakis CA; Kimonis V; Gahl WA; Wolfe L
Genet Med; 2017 Feb; 19(2):160-168. PubMed ID: 27388694
[TBL] [Abstract][Full Text] [Related]
22. An induced pluripotent stem cell line (TRNDi010-C) from a patient carrying a homozygous p.R401X mutation in the NGLY1 gene.
Yang S; Cheng YS; Li R; Pradhan M; Hong J; Beers J; Zou J; Liu C; Might M; Rodems S; Zheng W
Stem Cell Res; 2019 Aug; 39():101496. PubMed ID: 31326749
[TBL] [Abstract][Full Text] [Related]
23. Liver-specific deletion of Ngly1 causes abnormal nuclear morphology and lipid metabolism under food stress.
Fujihira H; Masahara-Negishi Y; Akimoto Y; Hirayama H; Lee HC; Story BA; Mueller WF; Jakob P; Clauder-Münster S; Steinmetz LM; Radhakrishnan SK; Kawakami H; Kamada Y; Miyoshi E; Yokomizo T; Suzuki T
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165588. PubMed ID: 31733337
[TBL] [Abstract][Full Text] [Related]
24. Transcriptome and functional analysis in a Drosophila model of NGLY1 deficiency provides insight into therapeutic approaches.
Owings KG; Lowry JB; Bi Y; Might M; Chow CY
Hum Mol Genet; 2018 Mar; 27(6):1055-1066. PubMed ID: 29346549
[TBL] [Abstract][Full Text] [Related]
25. A commentary on 'Patient-derived gene and protein expression signatures of NGLY1 deficiency'.
Suzuki T
J Biochem; 2024 Mar; 175(3):221-223. PubMed ID: 38156787
[TBL] [Abstract][Full Text] [Related]
26. Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie.
Imbach T; Schenk B; Schollen E; Burda P; Stutz A; Grunewald S; Bailie NM; King MD; Jaeken J; Matthijs G; Berger EG; Aebi M; Hennet T
J Clin Invest; 2000 Jan; 105(2):233-9. PubMed ID: 10642602
[TBL] [Abstract][Full Text] [Related]
27. JF1/B6F1 Ngly1
Asahina M; Fujinawa R; Fujihira H; Masahara-Negishi Y; Andou T; Tozawa R; Suzuki T
Proc Jpn Acad Ser B Phys Biol Sci; 2021; 97(2):89-102. PubMed ID: 33563880
[TBL] [Abstract][Full Text] [Related]
28. Mitochondrial function requires NGLY1.
Kong J; Peng M; Ostrovsky J; Kwon YJ; Oretsky O; McCormick EM; He M; Argon Y; Falk MJ
Mitochondrion; 2018 Jan; 38():6-16. PubMed ID: 28750948
[TBL] [Abstract][Full Text] [Related]
29. Assay for the peptide:N-glycanase/NGLY1 and disease-specific biomarkers for diagnosing NGLY1 deficiency.
Hirayama H; Suzuki T
J Biochem; 2022 Feb; 171(2):169-176. PubMed ID: 34791337
[TBL] [Abstract][Full Text] [Related]
30. Defining the phenotypical spectrum associated with variants in
Brock S; Vanderhasselt T; Vermaning S; Keymolen K; Régal L; Romaniello R; Wieczorek D; Storm TM; Schaeferhoff K; Hehr U; Kuechler A; Krägeloh-Mann I; Haack TB; Kasteleijn E; Schot R; Mancini GMS; Webster R; Mohammad S; Leventer RJ; Mirzaa G; Dobyns WB; Bahi-Buisson N; Meuwissen M; Jansen AC; Stouffs K
J Med Genet; 2021 Jan; 58(1):33-40. PubMed ID: 32571897
[TBL] [Abstract][Full Text] [Related]
31. Progressive myoclonic epilepsy as an expanding phenotype of NGLY1-associated congenital deglycosylation disorder: A case report and review of the literature.
Sonoda Y; Fujita A; Torio M; Mukaino T; Sakata A; Matsukura M; Yonemoto K; Hatae K; Ichimiya Y; Chong PF; Ochiai M; Wada Y; Kadoya M; Okamoto N; Murakami Y; Suzuki T; Isobe N; Shigeto H; Matsumoto N; Sakai Y; Ohga S
Eur J Med Genet; 2024 Feb; 67():104895. PubMed ID: 38070824
[TBL] [Abstract][Full Text] [Related]
32. Patient-derived gene and protein expression signatures of NGLY1 deficiency.
Rauscher B; Mueller WF; Clauder-Münster S; Jakob P; Islam MS; Sun H; Ghidelli-Disse S; Boesche M; Bantscheff M; Pflaumer H; Collier P; Haase B; Chen S; Hoffman R; Wang G; Benes V; Drewes G; Snyder M; Steinmetz LM
J Biochem; 2022 Feb; 171(2):187-199. PubMed ID: 34878535
[TBL] [Abstract][Full Text] [Related]
33. Generation of two gene corrected human isogenic iPSC lines (NCATS-CL6104 and NCATS-CL6105) from a patient line (NCATS-CL6103) carrying a homozygous p.R401X mutation in the NGLY1 gene using CRISPR/Cas9.
Pavlinov I; Farkhondeh A; Yang S; Xu M; Cheng YS; Beers J; Zou J; Liu C; Might M; Rodems S; Baumgärtel K; Zheng W
Stem Cell Res; 2021 Oct; 56():102554. PubMed ID: 34619643
[TBL] [Abstract][Full Text] [Related]
34. N-glycanase NGLY1 regulates mitochondrial homeostasis and inflammation through NRF1.
Yang K; Huang R; Fujihira H; Suzuki T; Yan N
J Exp Med; 2018 Oct; 215(10):2600-2616. PubMed ID: 30135079
[TBL] [Abstract][Full Text] [Related]
35. Calystegine B3 as a specific inhibitor for cytoplasmic alpha-mannosidase, Man2C1.
Kato A; Wang L; Ishii K; Seino J; Asano N; Suzuki T
J Biochem; 2011 Apr; 149(4):415-22. PubMed ID: 21217149
[TBL] [Abstract][Full Text] [Related]
36. Free oligosaccharides to monitor glycoprotein endoplasmic reticulum-associated degradation in Saccharomyces cerevisiae.
Hirayama H; Seino J; Kitajima T; Jigami Y; Suzuki T
J Biol Chem; 2010 Apr; 285(16):12390-404. PubMed ID: 20150426
[TBL] [Abstract][Full Text] [Related]
37. ELISA-based highly sensitive assay system for the detection of endogenous NGLY1 activity.
Fujihira H; Sato K; Nishiuchi Y; Murase T; Matsuda Y; Yoshida Y; Kamei T; Suzuki T
Biochem Biophys Res Commun; 2024 May; 710():149826. PubMed ID: 38581946
[TBL] [Abstract][Full Text] [Related]
38. Unexplained death in patients with NGLY1 mutations may be explained by adrenal insufficiency.
van Keulen BJ; Rotteveel J; Finken MJJ
Physiol Rep; 2019 Feb; 7(3):e13979. PubMed ID: 30740912
[TBL] [Abstract][Full Text] [Related]
39. MN1 C-terminal truncation syndrome is a novel neurodevelopmental and craniofacial disorder with partial rhombencephalosynapsis.
Mak CCY; Doherty D; Lin AE; Vegas N; Cho MT; Viot G; Dimartino C; Weisfeld-Adams JD; Lessel D; Joss S; Li C; Gonzaga-Jauregui C; Zarate YA; Ehmke N; Horn D; Troyer C; Kant SG; Lee Y; Ishak GE; Leung G; Barone Pritchard A; Yang S; Bend EG; Filippini F; Roadhouse C; Lebrun N; Mehaffey MG; Martin PM; Apple B; Millan F; Puk O; Hoffer MJV; Henderson LB; McGowan R; Wentzensen IM; Pei S; Zahir FR; Yu M; Gibson WT; Seman A; Steeves M; Murrell JR; Luettgen S; Francisco E; Strom TM; Amlie-Wolf L; Kaindl AM; Wilson WG; Halbach S; Basel-Salmon L; Lev-El N; Denecke J; Vissers LELM; Radtke K; Chelly J; Zackai E; Friedman JM; Bamshad MJ; Nickerson DA; ; Reid RR; Devriendt K; Chae JH; Stolerman E; McDougall C; Powis Z; Bienvenu T; Tan TY; Orenstein N; Dobyns WB; Shieh JT; Choi M; Waggoner D; Gripp KW; Parker MJ; Stoler J; Lyonnet S; Cormier-Daire V; Viskochil D; Hoffman TL; Amiel J; Chung BHY; Gordon CT
Brain; 2020 Jan; 143(1):55-68. PubMed ID: 31834374
[TBL] [Abstract][Full Text] [Related]
40. Ever-expanding NGLY1 biology.
Suzuki T; Yoshida Y
J Biochem; 2022 Feb; 171(2):141-143. PubMed ID: 34969094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
